Publications by authors named "Mark Chapelier"
Int Forum Allergy Rhinol
September 2018
Article Synopsis
- Sinonasal undifferentiated carcinoma (SNUC) is a rare cancer with a poor prognosis, and there's limited research on effective management strategies.
- A study analyzed treatment approaches and outcomes for 54 patients, revealing 3-year overall survival and recurrence-free survival rates of 62.4% and 47.8%, respectively, with many patients experiencing metastasis or recurrence.
- Induction chemotherapy significantly improved recurrence-free survival, suggesting that multimodal treatments may enhance SNUC prognosis, although more extensive studies are needed to confirm these findings.
